查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594001

醫療迴旋加速器市場：按產品類型、最終用戶分類 - 全球預測 2025-2030

Medical Cyclotron Market by Product Type (AVF Cyclotron, Ring Cyclotron), End Users (Hospital, Pharmaceutical, Specialized Clinics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年醫療迴旋加速器市場價值為3.5195億美元，預計到2024年將達到3.8735億美元，複合年成長率為10.54%，到2030年將達到7.0993億美元。

醫用迴旋加速器 迴旋加速器是一種用於生產放射性核種的粒子加速器，對於各種醫學診斷和治療，特別是核醫和 PET 掃描至關重要。對迴旋加速器的需求源於由於癌症和心血管疾病的增加而對先進醫學診斷工具的需求增加。迴旋加速器對於及時有效地生產放射性同位素非常重要，放射性同位素的壽命很短，需要從生產現場快速供應到醫療場域。醫療迴旋加速器的最終用途包括醫院、診斷中心和研究機構。

主要市場統計
基準年[2023] 35195萬美元
預測年份 [2024] 3.8735 億美元
預測年份 [2030] 70993萬美元
複合年成長率（%） 10.54%

醫療迴旋加速器市場的成長受到技術進步、醫療保健支出增加以及核醫療法越來越多採用的影響。潛在的機會存在於新興市場，這些市場對醫療保健基礎設施的投資正在增加，迴旋加速器技術的進步提高了效率並降低了營運成本。此外，公共機構和私人公司之間的夥伴關係正在促進更廣泛地獲取同位素並改善分銷網路。然而，他們面臨挑戰，包括安裝迴旋加速器的初始成本高昂、放射性核種生產的複雜法規以及操作先進設備的熟練勞動力有限。

技術創新將為迴旋加速器小型化和自動化提供重要機會，使生產變得更加容易且更具成本效益，即使對於小型醫療設施也是如此。新同位素的研究擴大了診斷和治療應用的範圍並擴大了市場潛力。儘管市場競爭激烈，幾乎沒有大公司，但隨著技術和醫學的進步，市場有開拓空間，市場正在蓬勃發展。希望進入或拓展該市場的公司必須優先考慮高效且具成本效益的解決方案，並考慮創新和技能開拓夥伴關係，以有效應對監管環境。

市場動態：揭示快速發展的醫療迴旋加速器市場的關鍵市場洞察

供需的動態交互作用正在改變醫療迴旋加速器市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 癌症和心血管疾病的增加
    • 使用 PET 掃描進行診斷治療的需求
    • 政府積極致力於癌症的早期發現和診斷
  • 市場限制因素
    • 醫用迴旋加速器高成本且缺乏適當的基礎設施
  • 市場機會
    • 核子醫學檢測的普及和使用迴旋加速器的放射性藥物生產的增加
    • 醫用迴旋加速器的技術進步與產品開發
  • 市場問題
    • 使用迴旋加速器生產新放射性同位素的限制

波特五力：駕馭醫療迴旋加速器市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解醫療迴旋加速器市場的外部影響

外部宏觀環境因素在塑造醫療迴旋加速器市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解醫療迴旋加速器市場的競爭格局

對醫療迴旋加速器市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：醫療迴旋加速器市場供應商的績效評估

FPNV定位矩陣是評估醫療迴旋加速器市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製醫療迴旋加速器市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，醫療迴旋加速器市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 癌症和心血管疾病的增加
      • 使用 PET 掃描進行診斷治療的需求
      • 政府優先採取的癌症早期檢測和診斷舉措
    • 抑制因素
      • 醫用迴旋加速器成本高且缺乏適當的基礎設施
    • 機會
      • 核子醫學掃描的普及和使用迴旋加速器增加放射性藥物的產量
      • 醫用迴旋加速器的技術進步與產品開發
    • 任務
      • 使用迴旋加速器生產新放射性同位素的限制
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章醫療迴旋加速器市場：依產品類型

  • 介紹
  • AVF迴旋加速器
  • 環形迴旋加速器

第7章醫療迴旋加速器市場：依最終用戶分類

  • 介紹
  • 醫院
  • 製藥
  • 專科診所

第8章美洲醫療迴旋加速器市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太醫療迴旋加速器市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲醫療迴旋加速器市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Advanced Cyclotron Systems, Inc.
  • ALCEN
  • Best Cyclotron Systems
  • Dr. Fritz Faulhaber GmbH & Co. KG
  • GE Healthcare
  • IBA Radiopharma Solutions
  • Ionetix Corporation
  • isoSolution Inc.
  • Molecular Cyclotrons Pvt Ltd.
  • Nueclear Healthcare Limited
  • Siemens AG
  • Sumitomo Heavy Industries, Ltd.
  • TeamBest
  • The Japan Steel Work Ltd.
  • Varian Medical Systems, Inc.
Product Code: MRR-957C47F92F8F

The Medical Cyclotron Market was valued at USD 351.95 million in 2023, expected to reach USD 387.35 million in 2024, and is projected to grow at a CAGR of 10.54%, to USD 709.93 million by 2030.

A medical cyclotron is a type of particle accelerator used in the production of radionuclides, which are crucial for various medical diagnostics and treatments, particularly in nuclear medicine and PET scans. The necessity of cyclotrons arises from the growing demand for advanced diagnostic tools in healthcare, driven by rising incidences of cancer and cardiovascular diseases. Cyclotrons are critical in enabling timely and efficient production of radioisotopes, which are short-lived and need quick delivery from production site to point of care. The end-use scope of medical cyclotrons spans hospitals, diagnostic centers, and research institutions.

KEY MARKET STATISTICS
Base Year [2023] USD 351.95 million
Estimated Year [2024] USD 387.35 million
Forecast Year [2030] USD 709.93 million
CAGR (%) 10.54%

Market growth for medical cyclotrons is influenced by technological advancements, rising healthcare spending, and increasing adoption of nuclear medicine therapies. Potential opportunities lie in emerging markets with increasing healthcare infrastructure investments, along with advancements in cyclotron technology enhancing efficiency and reducing operational costs. Additionally, partnerships between public institutions and private companies are encouraging wider access and improved distribution networks for isotopes. However, the market faces challenges such as the high initial cost of cyclotron installation, regulatory complexity surrounding radionuclide production, and a limited skilled workforce to operate sophisticated equipment.

Innovation presents significant opportunities in miniaturization and automation of cyclotrons, which would make production more accessible and cost-effective for smaller healthcare facilities. Research into new isotopes can expand the range of diagnostic and therapeutic applications, thus broadening market potential. The nature of the market is competitive, with few major players dominating, yet it remains dynamic with continued scope for development in response to technological and medical advancements. Companies looking to enter or expand in this market should prioritize high-efficiency, cost-effective solutions and consider partnerships for technological innovation and skill development to navigate the regulatory landscape effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Medical Cyclotron Market

The Medical Cyclotron Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cases of cancer and cardiovascular diseases
    • Demand for diagnostics treatments with PET scans
    • Favorable government initiatives for the early detection and diagnosis of cancer
  • Market Restraints
    • High cost of medical cyclotron and lack of proper infrastructure
  • Market Opportunities
    • Proliferation of nuclear medicine scans and increasing radiopharmaceutical production with cyclotron
    • Technological advancements and product developments in medical cyclotron
  • Market Challenges
    • Limitations related to the use of cyclotrons for the production of novel radioisotopes

Porter's Five Forces: A Strategic Tool for Navigating the Medical Cyclotron Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Medical Cyclotron Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Medical Cyclotron Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Medical Cyclotron Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Medical Cyclotron Market

A detailed market share analysis in the Medical Cyclotron Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Medical Cyclotron Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Medical Cyclotron Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Medical Cyclotron Market

A strategic analysis of the Medical Cyclotron Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Medical Cyclotron Market, highlighting leading vendors and their innovative profiles. These include Advanced Cyclotron Systems, Inc., ALCEN, Best Cyclotron Systems, Dr. Fritz Faulhaber GmbH & Co. KG, GE Healthcare, IBA Radiopharma Solutions, Ionetix Corporation, isoSolution Inc., Molecular Cyclotrons Pvt Ltd., Nueclear Healthcare Limited, Siemens AG, Sumitomo Heavy Industries, Ltd., TeamBest, The Japan Steel Work Ltd., and Varian Medical Systems, Inc..

Market Segmentation & Coverage

This research report categorizes the Medical Cyclotron Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across AVF Cyclotron and Ring Cyclotron.
  • Based on End Users, market is studied across Hospital, Pharmaceutical, and Specialized Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of cancer and cardiovascular diseases
      • 5.1.1.2. Demand for diagnostics treatments with PET scans
      • 5.1.1.3. Favorable government initiatives for the early detection and diagnosis of cancer
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of medical cyclotron and lack of proper infrastructure
    • 5.1.3. Opportunities
      • 5.1.3.1. Proliferation of nuclear medicine scans and increasing radiopharmaceutical production with cyclotron
      • 5.1.3.2. Technological advancements and product developments in medical cyclotron
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations related to the use of cyclotrons for the production of novel radioisotopes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical Cyclotron Market, by Product Type

  • 6.1. Introduction
  • 6.2. AVF Cyclotron
  • 6.3. Ring Cyclotron

7. Medical Cyclotron Market, by End Users

  • 7.1. Introduction
  • 7.2. Hospital
  • 7.3. Pharmaceutical
  • 7.4. Specialized Clinics

8. Americas Medical Cyclotron Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Medical Cyclotron Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Medical Cyclotron Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Cyclotron Systems, Inc.
  • 2. ALCEN
  • 3. Best Cyclotron Systems
  • 4. Dr. Fritz Faulhaber GmbH & Co. KG
  • 5. GE Healthcare
  • 6. IBA Radiopharma Solutions
  • 7. Ionetix Corporation
  • 8. isoSolution Inc.
  • 9. Molecular Cyclotrons Pvt Ltd.
  • 10. Nueclear Healthcare Limited
  • 11. Siemens AG
  • 12. Sumitomo Heavy Industries, Ltd.
  • 13. TeamBest
  • 14. The Japan Steel Work Ltd.
  • 15. Varian Medical Systems, Inc.

LIST OF FIGURES

  • FIGURE 1. MEDICAL CYCLOTRON MARKET RESEARCH PROCESS
  • FIGURE 2. MEDICAL CYCLOTRON MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. MEDICAL CYCLOTRON MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. MEDICAL CYCLOTRON MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MEDICAL CYCLOTRON MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MEDICAL CYCLOTRON MARKET DYNAMICS
  • TABLE 7. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY AVF CYCLOTRON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RING CYCLOTRON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 100. MEDICAL CYCLOTRON MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. MEDICAL CYCLOTRON MARKET, FPNV POSITIONING MATRIX, 2023